PI3K/mTOR Signaling Pathway Dual Inhibition for the Management of Neuroinflammation: Novel Insights from In Vitro ModelsAlessio Ardizzone(University of Messina), Marika Lanza(University of Messina)BiomoleculesMay 7, 202510.3390/biom15050677Cited by 4SaveCiteExport RISWatch citationsRelated PapersNew Insights into the Mechanism of Ulva pertusa on Colitis in Mice: Modulation of the Pain and Immune System|Marine Drugs|2023|24The Inhibition of Prolyl Endopeptidase (PREP) by KYP-2047 Treatment to Reduce Myocardial Ischemia/Reperfusion Injury|Antioxidants|2025|1PF-04691502, a PI3K/mTOR Dual Inhibitor, Ameliorates AD-like Pathology in a Mouse Model of AD|Cells|2025|0